Looking in the past— Neurotrope was so confident in Bryostatin-1 that they were not prepared, or experienced enough with the nuances of Clinical Trial Design
Looking into the future— (This is where we’re headed) Neurotrope now has fantastic support that is helping the company design a much better Clinical Trial that significantly increases the probability for this upcoming trial to meet its primary & secondary efficacy
Market Data 
Markets 
AI
